Add office photos
Employer?
Claim Account for FREE
Glenmark Pharmaceuticals
3.9
based on 2.8k Reviews
Company Overview
Company Locations
Working at Glenmark Pharmaceuticals
Company Summary
Glenmark Pharma is discovering advance therapies for a new world. Ceating centers of excellence in dermatology, oncology, etc
Overall Rating
3.9/5
based on 2.8k reviews
On-Par
with industry average
Critically rated for
Promotions
Work Policy
Work from office
75% employees reported
Monday to Saturday
62% employees reported
Flexible timing
63% employees reported
Within city
36% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
224 employees reported
Health insurance
200 employees reported
Office cab/shuttle
156 employees reported
Cafeteria
57 employees reported
View all benefits
About Glenmark Pharmaceuticals
Founded in1977 (48 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersMumbai, Maharashtra, India
Office Locations
--
Websiteglenmarkpharma.com
Primary Industry
Other Industries
--
Are you managing Glenmark Pharmaceuticals's employer brand? To edit company information,
claim this page for free
Glenmark is a leading global innovative pharmaceutical company committed to enriching lives worldwide. Our vision is to discover possibilities and make lives of patients better across the globe by developing cures for unmet medical needs. We have a rich pipeline of innovative molecules in various phases of development which are targeted in areas of oncology, respiratory and dermatology.
Managing your company's employer brand?
Claim this Company Page for FREE
Glenmark Pharmaceuticals Ratings
based on 2.8k reviews
Overall Rating
3.9/5
How AmbitionBox ratings work?
5
1.3k
4
757
3
379
2
133
1
191
Category Ratings
3.7
Company culture
3.7
Job security
3.7
Salary
3.7
Skill development
3.6
Work-life balance
3.5
Work satisfaction
3.3
Promotions
Glenmark Pharmaceuticals is rated 3.9 out of 5 stars on AmbitionBox, based on 2.8k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Glenmark Pharmaceuticals
based on 2.6k reviews
3.8
Rated by 201 Women
Rated 3.7 for Job security and 3.7 for Skill development
3.9
Rated by 2.4k Men
Rated 3.7 for Company culture and 3.7 for Salary
Work Policy at Glenmark Pharmaceuticals
based on 297 reviews in last 6 months
Work from office
75%
Hybrid
18%
Permanent work from home
7%
Glenmark Pharmaceuticals Reviews
Top mentions in Glenmark Pharmaceuticals Reviews
+ 5 more
Compare Glenmark Pharmaceuticals with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.9/5 based on 2.8k reviews | 4.0/5 based on 5.6k reviews | 4.1/5 based on 6.7k reviews | 5.0/5 based on 1 reviews |
Highly Rated for | No highly rated category | Salary Job security Skill development | Skill development Salary Work-life balance | Skill development Work-life balance Salary |
Critically Rated for | Promotions | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 75% employees reported | Work from office 83% employees reported | Work from office 72% employees reported | - |
Rating by Women Employees | 3.8 Good rated by 201 women | 4.0 Good rated by 417 women | 4.1 Good rated by 650 women | - no rating available |
Rating by Men Employees | 3.9 Good rated by 2.4k men | 4.0 Good rated by 4.9k men | 4.1 Good rated by 5.6k men | - no rating available |
Job security | 3.7 Good | 3.9 Good | 3.7 Good | 4.0 Good |
View more
Glenmark Pharmaceuticals Salaries
Glenmark Pharmaceuticals salaries have received with an average score of 3.7 out of 5 by 2.8k employees.
Senior Officer
(945 salaries)
Unlock
₹1.9 L/yr - ₹8.8 L/yr
Officer
(849 salaries)
Unlock
₹1.1 L/yr - ₹6.5 L/yr
Junior Officer
(319 salaries)
Unlock
₹1.9 L/yr - ₹5.9 L/yr
Research Officer
(307 salaries)
Unlock
₹4.5 L/yr - ₹10.8 L/yr
Research Associate
(275 salaries)
Unlock
₹2 L/yr - ₹7.5 L/yr
District Sales Manager
(253 salaries)
Unlock
₹4.2 L/yr - ₹10 L/yr
Production Officer
(249 salaries)
Unlock
₹1.8 L/yr - ₹6.2 L/yr
Field Sales Officer
(240 salaries)
Unlock
₹2.8 L/yr - ₹6.5 L/yr
Senior Research Officer
(193 salaries)
Unlock
₹7.5 L/yr - ₹15 L/yr
Medical Representative
(175 salaries)
Unlock
₹2 L/yr - ₹5.5 L/yr
Glenmark Pharmaceuticals Interview Questions
Interview questions by designation
Top Glenmark Pharmaceuticals interview questions and answers
Get interview-ready with top interview questions
Glenmark Pharmaceuticals Jobs
Glenmark Pharmaceuticals News
View all
Aurobindo Pharma, Glenmark, Zydus Recall Products In US
- Drug makers Aurobindo Pharma, Glenmark, and Zydus are recalling products in the US market due to manufacturing issues.
- Aurobindo Pharma USA Inc. is recalling over 1 lakh bottles of Cinacalcet tablets due to the presence of N-nitroso Cinacalcet impurity above FDA recommended limit.
- Glenmark Pharmaceuticals Inc, USA is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules due to the presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended limit.
- Zydus Pharmaceuticals (USA) Inc is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension due to a labeling error.
Bloomberg Quint | 15 Dec, 2024
Aurobindo Pharma, Glenmark recall products in US
- Aurobindo Pharma USA Inc, Glenmark Pharmaceuticals Inc, USA, and Zydus Pharmaceuticals (USA) Inc are recalling products in the US market due to manufacturing issues.
- Aurobindo Pharma is recalling over 1 lakh bottles of Cinacalcet tablets due to the presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit.
- Glenmark Pharmaceuticals is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules due to the presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Zydus Pharmaceuticals is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension due to a labelling error.
Yourstory | 15 Dec, 2024
Aurobindo, Glenmark, Zydus recall products in US over manufacturing issues
- Aurobindo Pharma USA Inc is recalling over 1 lakh bottles of Cinacalcet tablets in multiple strengths due to manufacturing issues.
- Glenmark Pharmaceuticals Inc, USA is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules (multiple strengths) due to the presence of certain impurities.
- Zydus Pharmaceuticals (USA) Inc is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension (40 mg) due to a labelling error.
- These recalls were initiated by the companies as per the guidelines of the USFDA to ensure consumer safety.
HinduBusinessLine | 15 Dec, 2024
Nifty Pharma, Healthcare Snap Two-Day Fall Post Jefferies' Outlook
- Nifty Pharma and Nifty Healthcare snapped their two-day fall and rose on Tuesday, following a report by Jefferies on its takeaways from its tour of pharma companies across Delhi, Mumbai, and Hyderabad.
- The report mentioned that non-price metrics are being given due importance for supplier selection and hospitals are looking to add new geographies once the home turf is well protected.
- Indian generic firms with meaningful exposure to the US market are adopting different strategies to avoid price erosion, such as moving up the value chain and pursuing complex products.
- In Nifty Healthcare, Glenmark Pharma, Syngene International, and Apollo Hospitals were among the top gainers, while Dr Reddy's Labs, Zydus Lifesciences, and Aurobindo Pharma fell the most.
Bloomberg Quint | 10 Dec, 2024
Glenmark’s subsidiary shows promising results in multiple Myeloma treatment
- Glenmark Pharmaceuticals' subsidiary has shown promising results in multiple myeloma treatment.
- In a Phase 1 study, the drug demonstrated an overall response rate of 83% among heavily pretreated patients.
- The treatment showed a favorable safety profile with no dose-limiting toxicities observed.
- The company plans to continue the study to establish the recommended Phase 2 dose and dosing schedule.
HinduBusinessLine | 10 Dec, 2024
Indian Pharma Market Grew 9.9% In November Driven By New Launches, Price Rise
- The Indian pharmaceutical market delivered a growth of 9.9% year-on-year in November 2024 driven by new launches and price rise.
- Except for respiratory and gynaecology, all other top therapies witnessed healthy growth, with derma seeing the highest growth at 15.8%.
- Ind-Ra expects Indian Pharma Market (IPM) growth to be around 8-9% YoY for fiscal 2025, compared to 6.5% YoY in fiscal 2024.
- Leading pharma companies like Alkem Laboratories, Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories, and Torrent Pharmaceuticals demonstrated strong performance.
Bloomberg Quint | 9 Dec, 2024
Stocks To Buy: Sun Pharma, Lupin, Glenmark Pharma Among DRChokseys Top Ideas In Pharma Sector
- Sun Pharma, Lupin, and Glenmark Pharma are among the top ideas in the pharma sector according to DRChoksey Research.
- Nifty Pharma is trading at a 1-year forward PE of 31.4 times, slightly above the 1-year average which is reasonable.
- NDTV Profit's special research section offers subscribers an opportunity to expand their understanding of companies, sectors, and the economy.
- Subscribe to NDTV Profit to unlock subscriber-only benefits such as access to stories, research reports, and exclusive content.
Bloomberg Quint | 26 Nov, 2024
Glenmark Pharma Q2 Results Review - India, Europe Drive Earnings: Motilal Oswal
- Glenmark Pharma Q2 results driven by India and Europe, according to Motilal Oswal.
- Earnings growth expected to strengthen over the next three years.
- Brokerage maintains a Buy rating on the stock.
- Glenmark Pharmaceuticals website is the source of the information.
Bloomberg Quint | 19 Nov, 2024
Glenmark Pharmaceuticals Q2 Results: Profit, Revenue Meet Estimates
- Glenmark Pharmaceuticals reports a net profit of Rs 354.5 crore in Q2 FY2025, marking a significant turnaround from the previous year's loss.
- Revenue for Q2 FY2025 increased by 7.1% to Rs 3,433.8 crore compared to Rs 3,207.4 crore in the year-ago period.
- EBITDA for the quarter rose by 30% to Rs 601.9 crore, with a margin expansion of 310 basis points to 17.5%.
- Shares of Glenmark Pharma closed 0.37% lower at Rs 1,533.70 apiece on the NSE.
Bloomberg Quint | 14 Nov, 2024
Indian Pharma Market Posts 6% Revenue Growth In October
- Indian Pharmaceuticals Market reported a 6.1% year-on-year growth in October.
- The growth was driven by a 5.2% increase in price and a 2.7% increase in new launches.
- Volume growth declined by 1.8% year on year.
- Glenmark Pharmaceuticals achieved the highest growth rate at 13.8%.
Bloomberg Quint | 13 Nov, 2024
Powered by
Compare Glenmark Pharmaceuticals with
Biocon Limited
3.9
Zydus Lifesciences
4.1
Torrent Pharmaceuticals
3.9
Lupin
4.2
Aurobindo Pharma
4.0
DIVI'S Laboratories
3.8
Piramal Group
3.8
Dr. Reddy's
4.1
Viatris
4.2
Alembic Pharmaceuticals
4.0
Ipca Laboratories
4.0
Abbott
4.1
Alkem Laboratories
3.9
Ajanta Pharma
4.0
Cadila Pharmaceuticals
3.5
AstraZeneca
4.1
Akums Drugs & Pharmaceuticals Limited
4.4
Pfizer
4.0
Novo Nordisk
4.1
GlaxoSmithKline Pharmaceuticals
4.1
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Glenmark Pharmaceuticals
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.6k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.7k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 5.9k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.4k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 5.9k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.6k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.3k reviews
Piramal Group
Pharma
3.8
• 1.1k reviews
Dr. Reddy's
Clinical Research, Pharma
4.1
• 6.6k reviews
Viatris
Manufacturing, Pharma
4.2
• 3k reviews
Glenmark Pharmaceuticals FAQs
When was Glenmark Pharmaceuticals founded?
Glenmark Pharmaceuticals was founded in 1977. The company has been operating for 48 years primarily in the Pharma sector.
Where is the Glenmark Pharmaceuticals headquarters located?
Glenmark Pharmaceuticals is headquartered in Mumbai, Maharashtra.
How many employees does Glenmark Pharmaceuticals have in India?
Glenmark Pharmaceuticals currently has more than 12,000+ employees in India. Marketing & Communication department appears to have the highest employee count in Glenmark Pharmaceuticals based on the number of reviews submitted on AmbitionBox.
Does Glenmark Pharmaceuticals have good work-life balance?
Glenmark Pharmaceuticals has a Work-Life Balance Rating of 3.6 out of 5 based on 2,700+ employee reviews on AmbitionBox. 75% employees rated Glenmark Pharmaceuticals 4 or above, while 25% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Glenmark Pharmaceuticals work-life balance reviews for more details
Is Glenmark Pharmaceuticals good for career growth?
Career growth at Glenmark Pharmaceuticals is rated as moderate, with a promotions and appraisal rating of 3.3. 25% employees rated Glenmark Pharmaceuticals 3 or below, while 75% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Glenmark Pharmaceuticals promotions/appraisals reviews for more detailed insights.
What are the cons of working in Glenmark Pharmaceuticals?
Working at Glenmark Pharmaceuticals does have some drawbacks that potential employees should consider. The company is poorly rated for promotions / appraisal, based on 2,700+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
